Community-Acquired Pseudomonas aeruginosa Meningitis in a Pediatric Patient

Alexander Cotran-Lenrow1, Lidia S Tefera2, Matthew Douglas-Vail3

  • 1Department of Microbiology, Partners in Health, Harper, LBR.

Cureus
|August 25, 2023
PubMed

Insights

This case report details a rare community-acquired Pseudomonas aeruginosa meningitis in a Liberian infant. Early diagnosis and treatment are vital, though long-term complications like hearing loss can occur.

Area of Science:

  • Pediatric Infectious Diseases
  • Neuroscience
  • Microbiology

Background:

  • Community-acquired bacterial meningitis poses significant risks, especially in resource-limited settings.
  • Pseudomonas aeruginosa meningitis is exceptionally rare in healthy children, often associated with severe outcomes.

Observation:

  • A 13-month-old boy in rural Liberia presented with fever, seizures, and altered consciousness.
  • Cerebrospinal fluid analysis revealed turbid fluid with elevated white blood cells, confirming bacterial meningitis.
  • Cerebrospinal fluid culture identified Pseudomonas aeruginosa as the causative pathogen.

Findings:

  • Prompt administration of antibiotics, including meropenem, led to clinical improvement.
  • The patient developed significant post-meningitis sequelae, including hearing and visual impairments.
  • This case highlights the challenges of diagnosing rare infections in resource-limited environments.

Implications:

  • Increased awareness and early recognition of Pseudomonas aeruginosa meningitis are crucial for timely intervention.
  • Effective management requires prompt antibiotic therapy and comprehensive follow-up care.
  • Addressing long-term sequelae through rehabilitation services is essential for improving patient outcomes.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
268
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
266
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
17
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
359